Hydromorphone Hydrochloride · #5 of 35 active shortages by FDA posting duration
Brand: HYDROMORPHONE HYDROCHLORIDE
FDA lists Hydromorphone Hydrochloride as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Unavailable
Hydromorphone Hydrochloride Injection: Active Shortage
Unavailable 26 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Hydromorphone Hydrochloride Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)
- Package NDC
- 63323-852-25
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Oct 31, 2017
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Next release March 2026. Check wholesalers for inventory.
Full Drug Profile
hydromorphone
Side effects, interactions, warnings & more
Nearby, Other Hydromorphone Shortage Records
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
FDA reason on file: Next release March 2026. General shortage guidance lives on the tracker hub.